Scarica l'app Stockscreener
0.228
4.16%
-0.0099
Pre-mercato:
.23
0.002
+0.88%
Precedente Chiudi:
$0.2379
Aprire:
$0.2295
Volume 24 ore:
629.06K
Relative Volume:
0.21
Capitalizzazione di mercato:
$4.67M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+14.00%
1M Prestazione:
-51.66%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.2061
$0.231
Intervallo di 1 settimana:
$0.1828
$0.2409
Portata 52W:
$0.1607
$1.09
Ping An Biomedical Co Ltd Stock (PASW) Company Profile
Nome
Ping An Biomedical Co Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PASW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PASW
Ping An Biomedical Co Ltd
|
0.228 | 4.88M | 0 | 0 | 0 | 0.00 |
|
AIN
Albany International Corp
|
55.49 | 1.61B | 1.27B | 100.39M | 116.84M | 3.20 |
|
UFI
Unifi Inc
|
3.86 | 72.34M | 583.56M | -53.59M | -18.48M | -2.97 |
|
CULP
Culp Inc
|
3.52 | 46.35M | 237.23M | -13.64M | -6.50M | -1.10 |
Ping An Biomedical Co Ltd Borsa (PASW) Ultime notizie
NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization - digitalmore.co
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session - Benzinga
FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session - Benzinga
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Morgan Stanley Lowers Price Target on JD.com to $24 From $28, Keeps Underweight Rating - marketscreener.com
These stocks that are showing activity before the opening bell on Tuesday. - Chartmill
Why Heritage Global Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? - Chartmill
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Trading Activity Highlights: Nasdaq & NYSE Leaders on January 12, 2026News and Statistics - IndexBox
Ping An Biomedical Secures Strategic Investment from Leading Chinese Tech and VC Executives to Accelerate Biopharma Growth - TipRanks
Ping An Biomedical Shares Surge After Securing Strategic Investment - Nasdaq
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Crypto: PASW Warning: Key Support Level Being Tested Right Now - InteractiveCrypto
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com India
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% By Investing.com - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session - Benzinga
Future Biotechnology Group Co., Ltd announced that it expects to receive $90 million in funding from Ping An Biomedical Co., Ltd. - marketscreener.com
Ping An Biomedical Co., Ltd. announced a financing transaction - MarketScreener
Ping An Biomedical (PASW) Stock: Gains Strategic Investors While Addressing Nasdaq Compliance - parameter.io
11 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga
Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com - Investing.com Australia
Remedy’s Nutrition® Unveils Hair Tissue Mineral Analysis: A Revolutionary Personalized Approach to Nutritional Wellness - The Manila Times
Ping An Bio to invest $90 million in Future Biotechnology Group By Investing.com - Investing.com South Africa
Shopley Announces Steve Levely as Chief Executive Officer - The Manila Times
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results - The Manila Times
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - The Manila Times
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry - The Manila Times
Sienna Announces Fourth Quarter 2025 Results Release Date and Conference Call - The Manila Times
Greenstone Files Early Warning Report for Marimaca Copper Corp. - The Manila Times
ACTG Launches IPACE-HIV to Study Frailty Intervention - The Manila Times
ProMach Acquires American Holt, DMA Solution, and Pride Engineering from Arcline - The Manila Times
Ping An Biomedical secures investment from three notable investors By Investing.com - Investing.com Nigeria
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - The Manila Times
uniQure Announces Type A Meeting Scheduled with FDA - The Manila Times
La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program - The Manila Times
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation - The Manila Times
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference - The Manila Times
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker 'LONA” - The Manila Times
H&R Block Tax Pro Review Free for New Clients with Purchase of DIY Products - The Manila Times
Nobel Announces Non-Brokered Private Placement Offering - The Manila Times
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - The Manila Times
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026 - The Manila Times
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger - The Manila Times
Ping An Biomedical Co Ltd Azioni (PASW) Dati Finanziari
Non sono disponibili dati finanziari per Ping An Biomedical Co Ltd (PASW). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):